KeyBanc analyst Ken Newman reiterated an Overweight rating and $155.00 price target on Emerson (NYSE: EMR).The analyst commented: "We View ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE